Chris Garabedian (Xontogeny)

Per­cep­tive Ad­vi­sors, Xon­toge­ny bring the band back and then some with a $515M sec­ond fund sniff­ing out lead com­pounds

When Per­cep­tive Ad­vi­sors and start­up ac­cel­er­a­tor Xon­toge­ny ini­tial­ly teamed up on an ear­ly-stage VC round in 2019, the part­ners hoped to prove their in­vest­ments could …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.